About Fortress Biotech Inc
- Industry: Biotechnology
- Exchange: NASDAQ NMS - GLOBAL MARKET
- Country: US
- Website: https://www.fortressbiotech.com/
Frequently Asked Questions
What is the 52-week range for FBIO?
The 52-week high is $4.53 and the 52-week low is $2.01.
What is the P/E ratio for FBIO?
The Price to Earnings (P/E) ratio is 0.61.
What is the dividend yield for FBIO?
This company does not currently pay a dividend or the data is unavailable.
What is the Return on Equity (ROE)?
The trailing twelve months (TTM) Return on Equity is 103.52%.
What is the Net Profit Margin?
The Net Profit Margin (TTM) is 163.32%.
What is the Price to Book (P/B) Ratio?
The annual Price to Book ratio stands at 2.28.
Analyst Recommendation Trends
Wall Street analyst consensus for FBIO over the last few months:
Latest FBIO News
Journey Medical Corporation to Participate in September 2026 Investor Conferences
SCOTTSDALE, Ariz., Sept. 08, 2026 (GLOBE NEWSWIRE) -- Journey Medical Corporation (“Journey Medical”) (Nasdaq: DERM), a commercial-stage pharmaceutical company focused on developing, selling and marketing U.S. Food and Drug Administration (“FDA”)-approved prescription pharmaceutical products for the treatment of dermatological conditions, today announced that Claude Maraoui, Co-Founder, President and Chief Executive Officer, will participate in two September 2026 investor conferences. Details of
Fortress Biotech to Present at the H.C. Wainwright 28th Annual Global Investment Conference
MIAMI, Sept. 08, 2026 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (Nasdaq: FBIO) (“Fortress”), an innovative biopharmaceutical company focused on acquiring and advancing assets to enhance long-term value for shareholders through product revenue, equity holdings and dividend and royalty income, today announced that Lindsay A. Rosenwald, M.D., Chairman, President and Chief Executive Officer, will present a corporate overview at the H.C. Wainwright 28th Annual Global Investment Conference. The prese
Related Stocks (Peers)
Recent Insider Transactions
| Date | Name | Shares Changed | Price | Value |
|---|---|---|---|---|
| 2026-10-01 | Jin David | +1,190 | $1.819 | $2,165 |
| 2026-06-22 | Jin David | +400,000 | - | - |
| 2026-04-01 | Jin David | +2,967 | $2.176 | $6,456 |
| 2026-03-18 | ROSENWALD LINDSAY A MD | +475,424 | - | - |
| 2026-03-18 | WEISS MICHAEL S | +475,424 | - | - |
| 2026-01-01 | Lorenz Kevin | +27,322 | - | - |
| 2026-01-01 | Klein Dov | +27,322 | - | - |
| 2026-01-01 | Harvey Jimmie | +27,322 | - | - |
| 2026-01-01 | Hoenlein Malcolm | +27,322 | - | - |
| 2026-01-01 | LOBELL J JAY | +27,322 | - | - |